Zobrazeno 1 - 10
of 220
pro vyhledávání: '"Taphoorn MJB"'
Autor:
van den Bent, MJ, Wefel, JS, Schiff, D, Taphoorn, MJB, Jaeckle, K, Junck, L, Armstrong, T, Choucair, A, Waldman, AD, Gorlia, T, Chamberlain, M, Baumert, BG, Vogelbaum, MA, Macdonald, DR, Reardon, DA, Wen, PY, Chang, SM, Jacobs, AH
Publikováno v:
In Lancet Oncology 2011 12(6):583-593
Autor:
Sztankay, M, Wintner, L, Roggendorf, S, Nordhausen, T, Dirven, L, Taphoorn, MJB, Verdonck- de Leeuw, IM, Velikova, G, Bottomley, A, Kulis, D, Schmidt, H
Publikováno v:
Who cares?-EbM und Transformation im Gesundheitswesen; 22. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin; 20210224-20210226; sine loco [digital]; DOC21ebmV-5-03 /20210223/
Hintergrund/Fragestellung: Unter Patient-Reported Outcomes (PROs) versteht man direkt von Patient*innen berichtete Aussagen z.B. zu ihrem Gesundheitszustand, ihrer medizinischen Behandlung, u.Ä., die mit standardisierten Fragebögen erhoben und nich
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34535742351c8f7c54f193a46665bb8d
Autor:
Klein, M, Heimans, JJ, Aaronson, NK, van der Ploeg, HM, Grit, J, Muller, M, Postma, TJ, Mooij, JJ, Boerman, RH, Beute, GN, Ossenkoppele, GJ, van Imhoff, GW, Dekker, AW, Jolles, J, Slotman, BJ, Struikmans, H, Taphoorn, MJB
Publikováno v:
In The Lancet 2 November 2002 360(9343):1361-1368
Autor:
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, Van Den Weyngaert D, Kaendler S, Krauseneck P, Vinolas N, Villa S, Wurm RE, Maillot MHB, Spagnolli F, Kantor G, Malhaire JP, Renard L, De Witte O, Scandolaro L, Vecht CJ, Maingon P, Lutterbach J, Kobierska A, Bolla M, Souchon R, Mitine C, Tzuk-Shina T, Kuten A, Haferkamp G, de Greve J, Priou F, Menten J, Rutten I, Clavere P, Malmstrom A, Jancar B, Newlands E, Pigott K, Twijnstra A, Chinot O, Reni M, Boiardi A, Fabbro M, Campone M, Bozzino J, Frenay M, Gijtenbeek J, Delattre JY, De Paula U, Hanzen C, Pavanato G, Schraub S, Pfeffer R, Soffietti R, Kortmann RD, Taphoorn M, Torrecilla JL, Grisold W, Huget P, Forsyth P, Fulton D, Kirby S, Wong R, Fenton D, Cairncross G, Whitlock P, Burdette-Radoux S, Gertler S, Saunders S, Laing K, Siddiqui J, Martin LA, Gulavita S, Perry J, Mason W, Thiessen B, Pai H, Alam ZY, Eisenstat D, Mingrone W, Hofer S, Pesce G, Dietrich PY, Thum P, Baumert B, Ryan G
Publikováno v:
New England Journal of Medicine, vol. 352, no. 10, pp. 987-96
New England Journal of Medicine, 352(10), 987-996. Massachussetts Medical Society
New England Journal of Medicine, 352(10), 987-996. Massachussetts Medical Society
BACKGROUND: Glioblastoma, the most common primary brain tumor in adults, is usually rapidly fatal. The current standard of care for newly diagnosed glioblastoma is surgical resection to the extent feasible, followed by adjuvant radiotherapy. In this
Autor:
Taphoorn, MJB
Publikováno v:
Taphoorn, MJB 2016, ' Similar Trials With Differing Outcomes: Reconciliation in Glioblastoma Reply ', Journal of Clinical Oncology, vol. 34, no. 3, pp. 292-U164 . https://doi.org/10.1200/JCO.2015.64.3072
Journal of Clinical Oncology, 34(3), 292-U164. American Society of Clinical Oncology
Journal of Clinical Oncology, 34(3), 292-U164. American Society of Clinical Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f216cc83b36a1bcf1d469acc55b11986
https://research.vumc.nl/en/publications/012d27ac-407b-44f0-bb09-5e7e33d44122
https://research.vumc.nl/en/publications/012d27ac-407b-44f0-bb09-5e7e33d44122
Autor:
van den Bent, Martin, Dubbink, Erik jan, Sanson, M, van der Lee-Haarloo, CR, Hegi, M, Jeuken, JWM, Ibdaih, A, Brandes, AA, Taphoorn, MJB, Frenay, M, Lacombe, D, Gorlia, T, Dinjens, Winand, Kros, J.M.
Publikováno v:
Journal of Clinical Oncology, 27(35), 5881-5886. American Society of Clinical Oncology
Purpose O6-methylguanine-methyltransferase (MGMT) promoter methylation has been shown to predict survival of patients with glioblastomas if temozolomide is added to radiotherapy (RT). It is unknown if MGMT promoter methylation is also predictive to o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::160015411edde2bc2b93c0a0fe9be5d5
https://pure.eur.nl/en/publications/e329edb1-900b-4048-ad95-fd7023cbc775
https://pure.eur.nl/en/publications/e329edb1-900b-4048-ad95-fd7023cbc775
Publikováno v:
Oncology Nursing Forum, 36(2), 225-231. Oncology Nursing Society
Purpose/Objectives: To investigate the toxicity of temozolomide (TMZ) in patients with brain tumors and appropriate nursing interventions. Design: Explorative analysis of prospective data. Setting: A IMZ clinic led by a nurse practitioner (NP). Sampl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::9feb019d31daf976b493101efdb7760f
https://pure.eur.nl/en/publications/bb816261-f798-4485-8064-11e4d9d31bea
https://pure.eur.nl/en/publications/bb816261-f798-4485-8064-11e4d9d31bea
Autor:
Mauer, M, Taphoorn, MJB, Bottomley, A, Coens, C, Delattre, JY, Brandes, AA, van der Rijt, Karin, Bernsen, HJJA, Frenay, M, Tijssen, CC, Efficace, F, Lacombe, D, Allgeier, A, van den Bent, Martin
Publikováno v:
Journal of Clinical Oncology, 25, 5731-5737. American Society of Clinical Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::1af55355d51748d50aaeddc0454d900b
https://pure.eur.nl/en/publications/e7cfab96-0da3-4eb6-9adb-ffd758b9a7d1
https://pure.eur.nl/en/publications/e7cfab96-0da3-4eb6-9adb-ffd758b9a7d1
Publikováno v:
Neuro-oncologie in de praktijk. Behandeling van gliomen, 1-1
STARTPAGE=1;ENDPAGE=1;TITLE=Neuro-oncologie in de praktijk. Behandeling van gliomen
STARTPAGE=1;ENDPAGE=1;TITLE=Neuro-oncologie in de praktijk. Behandeling van gliomen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::633251e6ad3266cf8be445687bfc3053
https://pure.eur.nl/en/publications/d7210c91-0136-4a73-bab0-e2dc0166e9af
https://pure.eur.nl/en/publications/d7210c91-0136-4a73-bab0-e2dc0166e9af
Publikováno v:
JOURNAL OF NEURO-ONCOLOGY, 52(1), 73-80. SPRINGER
A retrospective analysis of the clinical presentations and neuroimaging characteristics of 33 patients with a primary central nervous system lymphoma (PCNL) who received cranial radiotherapy was performed to assess incidence of and risk factors for r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::f4cbe625aef84fe6929bc730ec1e7a73
https://research.rug.nl/en/publications/f87fd13f-6fc4-4b56-b4ac-11ea36c6e70a
https://research.rug.nl/en/publications/f87fd13f-6fc4-4b56-b4ac-11ea36c6e70a